These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 47747)

  • 1. Anticoagulant activity of 3,3'-alkylthioalkylidene- and 3,3'-(5-alkylthiofurfurylidene)-bis-4-hydroxycoumarins and their oxidation products.
    Gumińska M; Eckstein M; Stachurska B
    Biochem Pharmacol; 1975 Jan; 24(1):67-70. PubMed ID: 47747
    [No Abstract]   [Full Text] [Related]  

  • 2. The anticoagulant activity of 3.3'-(p-alkylthio-benzylidene)-bis-4-hydroxycoumarins and their oxidation products.
    Gumińska M; Eckstein M; Stachurska B; Sulko J
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):277-86. PubMed ID: 5584958
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between distribution, elimination and anticoagulant action of dicumarol.
    Jähnchen E; Levy G
    J Pharmacol Exp Ther; 1974 Feb; 188(2):293-9. PubMed ID: 4129954
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 5. 4-hydroxycoumarin derivatives. X. 3,3'-Alkylthiofurfurylidene-bis-4-hydroxycoumarins and their oxidation products.
    Sulko J
    Farmaco Sci; 1971 Feb; 26(2):146-52. PubMed ID: 5542971
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experiences with 4-hydroxycoumarin anticoagulant No. 63 and the antagonistic effect of menadione and vitamin K.
    HANSON HH; BARKER NW; MANN FD
    Circulation; 1951 Dec; 4(6):844-63. PubMed ID: 14879492
    [No Abstract]   [Full Text] [Related]  

  • 7. The anticoagulant action of some derivatives of 3,3'-(arylidene)-bis-4-hydroxycoumarin.
    GUMINSKA M; ECKSTEIN M
    J Med Pharm Chem; 1961 May; 3():583-95. PubMed ID: 13902930
    [No Abstract]   [Full Text] [Related]  

  • 8. Hereditary resistance to coumarin anticoagulant drugs in man and rat.
    O'Reilly RA; Pool JG; Aggeler PM
    Ann N Y Acad Sci; 1968 Jul; 151(2):913-31. PubMed ID: 4189970
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of a new anticoagulant with a Dicoumarol-like structure: 3,3'-methylthiopropylidene-bis-(4-hydroxycoumarin) (M.T.H.)].
    BERGOGNE C; KAUFMANN H; CORABOEUF E; BRETON
    Sem Hop Ther Paris; 1962 Apr; 38():342-6. PubMed ID: 13867778
    [No Abstract]   [Full Text] [Related]  

  • 10. The second reported kindred with hereditary resistance to oral anticoagulant drugs.
    O'Reilly RA
    N Engl J Med; 1970 Jun; 282(26):1448-51. PubMed ID: 4192578
    [No Abstract]   [Full Text] [Related]  

  • 11. [CLINICAL EXPERIMENTATION OF A NEW ANTICOAGULANT DERIVATIVE OF DICOUMAROL: 3,3' METHYL-THIOPROPYLIDENE-BIS (4-HYDROXYCOUMARIN)].
    DESCOURS C; APPEAU A; DELAHAYE JP
    Lyon Med; 1964 Nov; 212():1089-98. PubMed ID: 14228680
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
    TOOHEY M
    Br Med J; 1952 Sep; 2(4786):687-90. PubMed ID: 12978288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulant of indirect action nitropharin].
    Lakin KM; Smirnova TV; Karaseva MG
    Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of vitamin K status in human subjects administered "minidose" warfarin.
    Bach AU; Anderson SA; Foley AL; Williams EC; Suttie JW
    Am J Clin Nutr; 1996 Dec; 64(6):894-902. PubMed ID: 8942414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the control of anticoagulant therapy.
    Owren PA
    Geriatrics; 1971 Aug; 26(8):74 passim. PubMed ID: 5096463
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics of anticoagulant effect of dicumarol in rats.
    Wingard LB; Levy G
    J Pharmacol Exp Ther; 1973 Jan; 184(1):253-60. PubMed ID: 4119618
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and biological evaluation of C-3 aliphatic coumarins as vitamin K antagonists.
    Montagut-Romans A; Boulven M; Jacolot M; Moebs-Sanchez S; Hascoët C; Hammed A; Besse S; Lemaire M; Benoit E; Lattard V; Popowycz F
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1598-1601. PubMed ID: 28254487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of SKF 525A on the kinetics and action of an antivitamin K in the rat].
    Thonnart N; Letist D; Reuse J
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):369-72. PubMed ID: 4848952
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the effect of anticoagulants on [3H]vitamin K1 metabolism and prothrombin complex activity in the rabbit.
    Park BK; Leck JB; Wilson AC; Serlin MJ; Breckenridge AM
    Biochem Pharmacol; 1979 Apr; 28(8):1323-9. PubMed ID: 444299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.